Lupin Ltd.

NSE: LUPIN | BSE: 500257 | ISIN: INE326A01037 | Industry: Pharmaceuticals
| Falling Comet
1919.7000 -62.95 (-3.18%)
NSE Apr 09, 2025 15:31 PM
Volume: 1.1M
 

logo
Lupin Ltd.
05 Aug 2022
1919.70
-3.18%
ICICI Securities Limited
Lupin’s Q1FY23 performance was disappointing on profitability front. It reported its worst-ever EBITDA margin of 6.2% (I-Sec: 7.3%) due to restructuring in the US as well as continuous impact of inflation on raw materials and freight. US revenue sharply declined to US$121mn (I-Sec: 180mn) vs US$172/181mn YoY/QoQ on ~US$40-50mn one-time impact of restructuring, inventory write-offs and withdrawal of products.
Lupin Ltd. has an average target of 2329.44 from 9 brokers.
More from Lupin Ltd.
Recommended